Spectral AI (MDAI) Stock: Buy, Sell, or Hold?
MDAI - Spectral AI, Inc. Class A Common Stock
$1.44
-0.06 (-4.00%)
▼
5d:
-4.64%
30d:
-11.11%
90d:
-12.2%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 10, 2026
16d
Get Alerted When MDAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MDAI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MDAI shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDAI is currently trading at $1.44, which is considered oversold relative to its 30-day fair value range of $1.53 to $1.66.
Technical Outlook: Technically, MDAI is in a downtrend. The price is currently testing key support at $1.43. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: MDAI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.11 (+255.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDAI is in a downtrend. The price is currently testing key support at $1.43. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: MDAI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.11 (+255.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.53 -
$1.66
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 255.1% below Wall St target ($5.11)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.53 -
$1.66
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.43
Resistance Level
$1.65
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.65
Wall Street Target
$5.11
(+255.1%)
Revenue Growth (YoY)
-30.4%
Profit Margin
-65.5%
Share & Embed Analysis
Last updated: October 24, 2026 12:19 PM ET
Data refreshes hourly during market hours. Next update: 1:19 PM
Data refreshes hourly during market hours. Next update: 1:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 38 SELL |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 70 BUY |